Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Entresto med?

See the DrugPatentWatch profile for Entresto

What is Entresto (the “Entresto med” people usually mean)?

Entresto is the brand name for sacubitril/valsartan, a medicine used to treat certain types of heart failure in adults. It combines two components: sacubitril (a neprilysin inhibitor) and valsartan (an angiotensin II receptor blocker, or ARB).

What conditions does Entresto treat?

Entresto is used in heart failure patients, including people with:
- Reduced ejection fraction (HFrEF)
- Heart failure with preserved ejection fraction (HFpEF) (in the approved patient groups)

Exact eligibility depends on the prescribing indication and local labeling.

What side effects do patients ask about most?

Commonly discussed side effects for Entresto include:
- Low blood pressure (hypotension)
- High potassium (hyperkalemia)
- Kidney function changes
- Dizziness

Patients also need to be screened for risks related to blood pressure and kidney function before and during treatment.

How is Entresto taken (and what should patients know)?

Entresto is an oral prescription medication. The dose is typically adjusted based on factors like:
- Blood pressure
- Kidney function
- Whether the patient is already taking other heart failure meds
- Tolerability

It is generally taken on a regular schedule (often twice daily), as directed by a clinician.

Is there anything important to know about drug interactions?

Two practical interaction issues patients commonly need to know:
- Do not combine with ACE inhibitors due to risk of angioedema.
- Other blood pressure–lowering medicines may increase the chance of low blood pressure.

Clinicians follow the required washout periods when switching between these drug classes.

Is there a generic or alternative to Entresto?

Whether a cheaper alternative is available depends on country and the current status of patents/exclusivity. You can check up-to-date patent and market exclusivity details at DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “Entresto” or “sacubitril valsartan”).

Who makes Entresto?

Entresto is marketed by Novartis (brand owner), with its specific commercialization details depending on the market.

What’s the best next step if you meant something more specific?

“Entresto med” can mean different things (side effects, cost, dosage, whether it’s a blood pressure med, generic status, or patent/exclusivity). If you tell me your goal—like cost, generic availability, dose/administration, or side effects—and your country, I can tailor the answer.



Other Questions About Entresto :

entresto 49/51 pret Entresto lower bp? Why is entresto so expensive? Is the drug patent for entresto ending soon. what happens? Novartis entresto? Entresto patent expiration greece? Does entresto cause low blood pressure?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
62
Visibility
63
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

the brand name for sacubitril/valsartan


Core Claims
  • Entresto is the brand name for sacubitril/valsartan.
  • It is used to treat certain types of heart failure in adults.
  • It combines sacubitril and valsartan.
  • Common side effects discussed include hypotension, hyperkalemia, kidney function changes, and dizziness.
Differentiators
  • Defined as sacubitril/valsartan (two-component combination).
  • Includes interaction guidance such as not combining with ACE inhibitors due to risk of angioedema.

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Novartis 37%
50 #8 No